Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perception of Action Opportunities for Obstacle Crossing in Individuals With Parkinson's Disease: Associations With Motor and Cognitive Impairments and Self-Awareness

NCT07907770 is registered in ClinicalTrials.gov with University of Haifa as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07907770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Perception of Action Opportunities for Obstacle Crossing in Individuals With Parkinson's Disease: Associations With Motor and Cognitive Impairments and Self-Awareness
Lead sponsor
University of Haifa
Phase
Observational
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
November 1, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

older adults (65-85 years), parkinson disease (disorder)

Arms

As registered; 2 arms.

  • 1. Parkinson's Disease Obstacle Crossing Task

    Individuals diagnosed with Parkinson's disease, aged 65-85, capable of walking independently outdoors

  • 2. Healthy Controls Obstacle Crossing Task

    Healthy older adults, aged 65-85, without Parkinson's disease or other neurological conditions, capable of walking independently outdoors

Primary endpoints

Registered primary outcome measures; 2 primary.

  • 1. Judgment error Baseline (single session, up to 2 hours)

    Calculated as the absolute difference (in cm) between the estimated maximum obstacle height and the actual maximum height successfully crossed

  • 2. Normalized Estimated Maximum Obstacle Crossing Height Baseline (single session, up to 2 hours)

    The estimated maximum obstacle height the participant believes they can cross, normalized to the participant's leg length

Lead sponsor's other trials

University of Haifa, most recent start first.

Similar trials

Same condition (Parkinson Disease) and phase, most recent start first.